Compare BIO-TECHNE Corp (TECH) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Direxion Daily TSLA Bull 2X Shares — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.37B), while Direxion Daily TSLA Bull 2X Shares trades at $10.25 (market cap $4.08B). The key difference: BIO-TECHNE Corp is far larger — about 2.8× Direxion Daily TSLA Bull 2X Shares's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Direxion Daily TSLA Bull 2X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and Direxion Daily TSLA Bull 2X Shares for 15 Days on average.
| TECH | TSLL | |
|---|---|---|
Market Cap | $11.37B | $4.08B |
Volume | 3,153,511 | 46,206,477 |
Sector | Health | Leveraged / Inverse |
52-Week High | $72.61 | $23.03 |
52-Week Low | $43.31 | $6.74 |
Typical Hold Time | 63 Days | 15 Days |
Enterprise Value | $11.40B | — |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
TSLL, the Direxion Daily TSLA Bull 2X Shares ETF, trades at $10.15, down 1.55% on the day. The overall technical signal is bullish, supported by moving averages, while oscillators are neutral. Recent news highlights its sensitivity to Tesla's stock movements, with a notable rally tied to Cybercab hype. As a leveraged ETF, it aims to deliver twice Tesla's daily returns, amplifying both gains and losses.
The outlook for TSLL is directly tied to Tesla's performance, offering high-risk, high-reward exposure. Key risks include volatility decay from daily rebalancing and dependence on Tesla-specific events. Investors seeking amplified Tesla returns may find opportunity, but must be wary of the inherent leverage risks in a volatile stock.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
